Blog
RSS FeedPosted by Michael Wonder on 04 May 2018
Health data governance enforceable undertaking for re-identification of MBS/PBS data
3 May 2018 - The Australian Information Commissioner has concluded an investigation into the re-identification of Medicare service provider data ...
Posted by Michael Wonder on 27 Apr 2018
CMS Administrator Verma unveils new strategy to fuel data-driven patient care, transparency
26 April 2018 - New Medicare Advantage data resource released. ...
Posted by Michael Wonder on 18 Apr 2018
Post-marketing modifications of drug labels for cancer drugs approved by the US FDA between 2006 and 2016 with and without supporting randomized controlled trials
11 April 2018 - Modifications in cancer drug indications, dosing, and related toxicities after FDA approval are common. It is unclear ...
Posted by Michael Wonder on 30 Mar 2018
Guilty: Health Department breached privacy laws publishing data of 2.5 million people
29 March 2018 - The federal Department of Health "unintentionally" breached privacy laws when it published de-identified health records of ...
Posted by Michael Wonder on 01 Feb 2018
A revolution in health care is coming
1 February 2018 - Welcome to Doctor you. ...
Posted by Michael Wonder on 29 Dec 2017
ICER’s guideline on the acceptance and use of “in-confidence” data from manufacturers of pharmaceuticals, devices, and other health care interventions
22 December 2017 - ICER takes its obligations to transparency and fairness seriously. ...
Posted by Michael Wonder on 18 Dec 2017
Not so anonymous: Medicare data can be used to identify individual patients, researchers say
18 December 2017 - Researchers say they can identify individuals in government healthcare data that was supposed to be anonymous, ...
Posted by Michael Wonder on 14 Dec 2017
Report on the collection of under co-payment data 2016-17
14 December 2017 - From 1 July 2016 to 30 June 2017, approximately 85 million under co-payment prescriptions were supplied ...
Posted by Michael Wonder on 05 Dec 2017
Canada's regulator of patented drug prices is rigging data, and risking our health
5 December 2017 - The patent medicine pricing board is making a blatant attempt to bias the data. ...
Posted by Michael Wonder on 29 Nov 2017
Is the FDA withholding data about a controversial drug to protect its manufacturer?
29 November 2017 - In the case of Sarepta, it sure looks that way. ...
Posted by Michael Wonder on 22 Nov 2017
Chemotherapy compounder ID mandatory within PBS claims from 1 December 2017
22 November 2017 - From 1 December 2017, approved suppliers (approved pharmacists, approved medical practitioners and approved public and private ...
Posted by Michael Wonder on 21 Nov 2017
New 'powerful' cancer website for doctors
22 November 2017 - Quality national data on cancer in Australia is now available to clinicians via the National Cancer Control ...
Posted by Michael Wonder on 20 Nov 2017
Use of health care databases to support supplemental indications of approved medications
20 November 2017 - Can health care databases be used to confirm a supplemental indication that has been demonstrated in a ...
Posted by Michael Wonder on 24 Oct 2017
Can ad hoc analyses of clinical trials help personalise treatment decisions?
23 October 2017 - The value of ad hoc analyses of clinical trials may not be clear. Ad hoc analyses are ...
Posted by Michael Wonder on 20 Oct 2017
Unparalleled access to clinical data - one year on
20 October 2017 - Over 3,000 clinical documents published, 3,600 registered users and positive stakeholder feedback. ...